Solstein Capital’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.7K | Buy |
+249
| New | +$21.7K | 0.01% | 270 |
|
|
2022
Q3 | – | Sell |
-412
| Closed | -$31K | – | 314 |
|
|
2022
Q2 | $31K | Hold |
412
| – | – | 0.02% | 202 |
|
|
2022
Q1 | $53K | Hold |
412
| – | – | 0.03% | 183 |
|
|
2021
Q4 | $55K | Hold |
412
| – | – | 0.03% | 203 |
|
|
2021
Q3 | $56K | Hold |
412
| – | – | 0.03% | 217 |
|
|
2021
Q2 | $44K | Hold |
412
| – | – | 0.05% | 227 |
|
|
2021
Q1 | $37K | Buy |
+412
| New | +$37K | 0.05% | 214 |
|
|
2020
Q4 | – | Sell |
-412
| Closed | -$42K | – | 120 |
|
|
2020
Q3 | $42K | Hold |
412
| – | – | 0.09% | 138 |
|
|
2020
Q2 | $42K | Hold |
412
| – | – | 0.1% | 121 |
|
|
2020
Q1 | $28K | Hold |
412
| – | – | 0.11% | 111 |
|
|
2019
Q4 | $23K | Buy |
+412
| New | +$23K | 0.05% | 172 |
|